This study tested the hypothesis that pioglitazone reduces endothelin-1 activity in the forearm vasculature in non-diabetic patients with hypertension or hypercholesterolemia and variable degrees of insulin resistance.

Campia, U., Matuskey, L., Tesauro, M., Cardillo, C., Panza, J., PPARγ activation does not affect endothelin activity in non-diabetic patients with hypertension or hypercholesterolemia, <<ATHEROSCLEROSIS>>, 2014; 234 (2): 436-440. [doi:10.1016/j.atherosclerosis.2014.03.035] [http://hdl.handle.net/10807/64371]

PPARγ activation does not affect endothelin activity in non-diabetic patients with hypertension or hypercholesterolemia

Cardillo, Carmine;
2014

Abstract

This study tested the hypothesis that pioglitazone reduces endothelin-1 activity in the forearm vasculature in non-diabetic patients with hypertension or hypercholesterolemia and variable degrees of insulin resistance.
2014
Inglese
Campia, U., Matuskey, L., Tesauro, M., Cardillo, C., Panza, J., PPARγ activation does not affect endothelin activity in non-diabetic patients with hypertension or hypercholesterolemia, <<ATHEROSCLEROSIS>>, 2014; 234 (2): 436-440. [doi:10.1016/j.atherosclerosis.2014.03.035] [http://hdl.handle.net/10807/64371]
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10807/64371
Citazioni
  • ???jsp.display-item.citation.pmc??? 2
  • Scopus 4
  • ???jsp.display-item.citation.isi??? 2
social impact